Pepinemab

CAS No. 2097151-87-4

Pepinemab( —— )

Catalog No. M36877 CAS No. 2097151-87-4

Pepinemab(VX 15/2503) is a humanized IgG4 monoclonal antibody targeting sematone 4D.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 301 Get Quote
5MG 549 Get Quote
10MG 882 Get Quote
25MG 1270 Get Quote
50MG 1711 Get Quote
100MG 2241 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pepinemab
  • Note
    Research use only, not for human use.
  • Brief Description
    Pepinemab(VX 15/2503) is a humanized IgG4 monoclonal antibody targeting sematone 4D.
  • Description
    Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2097151-87-4
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Elizabeth E Evans, et al. Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. J Neuroinflammation. 2022 Aug 6;19(1):200.?
molnova catalog
related products
  • Phosphatidylcholines...

    Phosphatidylcholines,soya is a phosphatidylcholine from soybean used in the preparation of liposomes.

  • VT103

    VT103 is an orally active and selective inhibitor of TEAD1 protein palmitoylation and is an analog of VT101.

  • IQB-782

    IQB-782 is a mucolytic agent with mucolytic expectorant activity.IQB-782 inhibits thrombin-activating fibrinolytic inhibitor (TAFI), protects rats from tobacco smoke-induced respiratory obstruction.